| RS1362592984 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS1362597973 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1362599473 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1362606570 |
CENPF
|
Health Risk |
Likely pathogenic |
— |
| RS1362615818 |
SGCD
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS1362619480 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 26, Myofibrillar myopathy 5 |
| RS1362644811 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1362648752 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Wolfram syndrome 1, Wolfram syndrome |
| RS1362663440 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS1362664502 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1362690516 |
IFITM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS1362710187 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1362719565 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS1362738445 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Danon disease |
| RS1362746093 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1362758319 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1362771214 |
ZFP57
|
Health Risk |
Likely pathogenic |
— |
| RS1362774341 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1362774896 |
ARL13B
|
Health Risk |
Pathogenic |
Joubert syndrome 8, Joubert syndrome 8 |
| RS1362796016 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1362798167 |
AIPL1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS1362830842 |
DNAJC21
|
Health Risk |
Likely pathogenic |
— |
| RS1362833043 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS1362844961 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1362847020 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1362848762 |
NEK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1362872776 |
C5
|
Health Risk |
Likely pathogenic |
— |
| RS1362873316 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1362890886 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1362893874 |
ZNF335
|
Health Risk |
Pathogenic |
— |
| RS1362905226 |
HADHA
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1362906637 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Heimler syndrome 1, Heimler syndrome 1 |
| RS1362935450 |
ERCC6
|
Health Risk |
Pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1362937677 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS1362938038 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS1362962336 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS1362964563 |
ABCA4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Age related macular degeneration 2 |
| RS1362985118 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1362994447 |
ACTG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS1363004176 |
NBEA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1363009203 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
CACNA1G-related disorder, Inborn genetic diseases |
| RS1363011952 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1363012434 |
SYNGAP1
|
Health Risk |
Pathogenic |
— |
| RS1363014007 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS1363017615 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1363032805 |
NPHP3
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1363034255 |
GFER
|
Health Risk |
Pathogenic |
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome, Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome |
| RS1363043396 |
ADA
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1363058249 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1363062305 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 1, 3M syndrome 1 |
| RS1363070884 |
ATP2B2
|
Health Risk |
Pathogenic |
— |
| RS1363096463 |
USP9X
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1363099908 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1363104728 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS1363121734 |
ATP6V1B1
|
Health Risk |
Likely pathogenic |
Renal tubular acidosis with progressive nerve deafness, Malignant tumor of urinary bladder |
| RS1363124795 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1363125797 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1363133370 |
PHIP
|
Health Risk |
Likely pathogenic |
— |
| RS1363162720 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1DD |
| RS1363164647 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1363166555 |
TYR
|
Health Risk |
Likely pathogenic |
— |
| RS1363186839 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1363188459 |
CIB2
|
Health Risk |
Likely pathogenic |
— |
| RS1363198922 |
PPFIBP1
|
Health Risk |
Pathogenic |
Microcephaly, Severe intellectual disability |
| RS1363207852 |
KCNH1
|
Health Risk |
Conflicting classifications of pathogenicity |
KCNH1-related disorder, KCNH1-related disorder |
| RS1363237554 |
LARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile liver failure syndrome 1, Infantile liver failure syndrome 1 |
| RS1363245838 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1363248710 |
UBA5
|
Health Risk |
Likely pathogenic |
— |
| RS1363265634 |
SDHC
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1363268262 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1363277825 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS1363290269 |
COL4A1
|
Health Risk |
Likely pathogenic |
Sarcoma, Sarcoma |
| RS1363298408 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS1363308293 |
SLC16A2
|
Health Risk |
Likely pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS1363308991 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1363313204 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1363345814 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS1363348500 |
PSMC3
|
Health Risk |
Pathogenic |
12 conditions, 12 conditions |
| RS1363359148 |
CEP78
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1363364769 |
CCDC40
|
Health Risk |
Pathogenic |
Heterotaxy, Heterotaxy |
| RS1363364803 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1363366811 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS1363382746 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1363396787 |
DVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1363412937 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1363426044 |
TRAF3IP1
|
Health Risk |
Likely pathogenic |
— |
| RS1363433371 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1363441287 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Alport syndrome |
| RS1363445022 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1363451641 |
AARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS1363452328 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1363475546 |
BCS1L
|
Health Risk |
Pathogenic/Likely pathogenic |
GRACILE syndrome, Pili torti-deafness syndrome |
| RS1363486576 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1363491382 |
CEP78
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1363494222 |
LAT
|
Health Risk |
Likely pathogenic |
— |
| RS1363497653 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1363498219 |
BBS10
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1363500354 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS1363507110 |
LYZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyloidosis |
| RS1363518429 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |